ConductScience.org, home

Paper42007156

The impact of anti-vascular endothelial growth factor therapy on the activation status of retinal macrophages/microglia in patients with diabetic retinopathy and familial exudative vitreoretinopathy and its association with treatment response.

Li J and 5 others. Am J Transl Res, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. The impact of anti-vascular endothelial growth factor therapy on the activation status of retinal macrophages/microglia in patients with diabetic retinopathy and familial exudative vitreoretinopathy and its association with treatment response. Papers, record 42007156. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42007156

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The impact of anti-vascular endothelial growth factor therapy on the activation status of retinal macrophages/microglia in patients with diabetic retinopathy and familial exudative vitreoretinopathy and its association with treatment response.
PubMed
Journal
Am J Transl Res
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li JJiakai
2Fei PPing
3Zhang XXiang
4Rao YYuqing
5Li JJing
6Zhao PPeiquan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136254977Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy.Neural Regen Res2023https://conductscience.org/library/papers/36254977PubMed
239367441Insights to Ang/Tie signaling pathway: another rosy dawn for treating retinal and choroidal vascular diseases.J Transl Med2024https://conductscience.org/library/papers/39367441PubMed
339914485Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular Edema.Ophthalmol Retina2025https://conductscience.org/library/papers/39914485PubMed
438250154Angiogenic and Fibrogenic Dual-effect of Gremlin1 on Proliferative Diabetic Retinopathy.Int J Biol Sci2024https://conductscience.org/library/papers/38250154PubMed
537404990Retinal glia and NF-κB in diabetic retinopathy pathogenesis.Ann Transl Med2023https://conductscience.org/library/papers/37404990PubMed
639388397Optimization of individualized faricimab dosing for patients with diabetic macular edema: Protocol for the SWAN open-label, single-arm clinical trial.PLoS One2024https://conductscience.org/library/papers/39388397PubMed
738592149The Treatment of Diabetic Retinal Edema with Intravitreal Steroids: How and When.J Clin Med2024https://conductscience.org/library/papers/38592149PubMed
839882395Clinical Evaluation of Faricimab in Real-World Diabetic Macular Edema in India- A Multicenter Observational Study.Clin Ophthalmol2025https://conductscience.org/library/papers/39882395PubMed
937482199Activation of aryl hydrocarbon receptor by azatyrosine-phenylbutyric hydroxamide inhibits progression of diabetic retinopathy mice.Biochem Pharmacol2023https://conductscience.org/library/papers/37482199PubMed
1037007562Inhibition of NF-κB ameliorates aberrant retinal glia activation and inflammatory responses in streptozotocin-induced diabetic rats.Ann Transl Med2023https://conductscience.org/library/papers/37007562PubMed
1138892258The Severity of Diabetic Retinopathy Corresponds with Corneal Nerve Alterations and Ocular Discomfort of the Patient.Int J Mol Sci2024https://conductscience.org/library/papers/38892258PubMed
1236736895Longitudinal Quantitative Ultrawide-field Fluorescein Angiography Dynamics in the RUBY Diabetic Macular Edema Study.Ophthalmol Retina2023https://conductscience.org/library/papers/36736895PubMed
1339031809Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases.Adv Sci (Weinh)2024https://conductscience.org/library/papers/39031809PubMed
1438626646Genipin ameliorates diabetic retinopathy via the HIF-1α and AGEs-RAGE pathways.Phytomedicine2024https://conductscience.org/library/papers/38626646PubMed
1540180022Nitric oxide mediates negative feedback on the TXNIP/NLRP3 inflammasome pathway to prevent retinal neurovascular unit dysfunction in early diabetic retinopathy.Free Radic Biol Med2025https://conductscience.org/library/papers/40180022PubMed
1639658713Visual and anatomical failure of anti-VEGF therapy for retinal vascular diseases: a survival analysis of real-world data.Eye (Lond)2025https://conductscience.org/library/papers/39658713PubMed
1739260060Heme: A link between hemorrhage and retinopathy of prematurity progression.Redox Biol2024https://conductscience.org/library/papers/39260060PubMed
1838918759Therapeutic intervention in neuroinflammation for neovascular ocular diseases through targeting the cGAS-STING-necroptosis pathway.J Neuroinflammation2024https://conductscience.org/library/papers/38918759PubMed
1936984630Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections.Medicina (Kaunas)2023https://conductscience.org/library/papers/36984630PubMed
2037481454The additive effect of intravitreal dexamethasone combined with bevacizumab in refractory diabetic macular edema.J Fr Ophtalmol2023https://conductscience.org/library/papers/37481454PubMed

See all 38 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42720425Structural and Angiographic Assessment of the Nerve Fiber Layer in Age-Related Macular Degeneration and Diabetic Retinopathy.Invest Ophthalmol Vis Sci2026https://conductscience.org/library/papers/42720425

Source PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL1B3553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42007156

GET https://conductscience.org/api/papers/v1/42007156/references?page=2